kidney disease Archive — Page 2 of 6
-
October 27, 2022
Terker selected as VUMC Discovery Scholar in Health and Medicine
-
October 20, 2022
Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage
-
October 6, 2022
Kidney diseases research collaboration renewed
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases. -
August 25, 2022
Inflammatory driver of obesity
Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity. -
May 12, 2022
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. -
February 2, 2022
VUMC study raises hope for improving treatment of kidney disease
Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure. -
February 1, 2022
Accelerating podocyte production
A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.